Genomics Proteomics Core

$203,618U54FY2013AINIH

Colorado State University, Fort Collins CO

Investigators

Linked publications & trials

Paper 35357191 Paper 31748396 Paper 31537423 Paper 31383661 Paper 31115302 Paper 30798551 Paper 30256166 Paper 30024368 Paper 29882740 Paper 28986831 Paper 28951422 Paper 28874476 Paper 28769016 Paper 28462731 Paper 28081127 Paper 28039270 Paper 27956524 Paper 27865404 Paper 27632563 Paper 27620956 Paper 27457407 Paper 27412594 Paper 27194767 Paper 27126613 Paper 27053560 Paper 26913918 Paper 26711764 Paper 26711718 Paper 26456301 Paper 26368052 Paper 26331679 Paper 26186980 Paper 26105817 Paper 26075394 Paper 25903827 Paper 25824664 Paper 25747802 Paper 25650400 Paper 25630058 Paper 25533446 Paper 25514423 Paper 25494920 Paper 25486933 Paper 25403177 Paper 25373479 Paper 25233339 Paper 25121731 Paper 25078691 Paper 25049383 Paper 24920798 Paper 24920796 Paper 24744377 Paper 24597618 Paper 24571408 Paper 24486952 Paper 24393669 Paper 24386500 Paper 24379895 Paper 24379198 Paper 24364842 Paper 24351796 Paper 24339774 Paper 24277048 Paper 24260378 Paper 24257615 Paper 24252694 Paper 24243399 Paper 24222381 Paper 24210824 Paper 24198425 Paper 24158383 Paper 24101688 Paper 24084488 Paper 24070784 Paper 24062483 Paper 24055448 Paper 23959031 Paper 23929625 Paper 23856782 Paper 23848607 Paper 23822773 Paper 23817379 Paper 23774604 Paper 23732875 Paper 23641019 Paper 23628166 Paper 23584769 Paper 23544138 Paper 23540686 Paper 23509261 Paper 23375378 Paper 23312946 Paper 23305775 Paper 23301074 Paper 23253877 Paper 23231488 Paper 23226473 Paper 23217612 Paper 23201280 Paper 23185074

Abstract

The goal of the Genomics Proteomics Core (Core E) of the Rocky Mountain Regional Center of Excellence in Biodefense (RMRCE) is to provide post-genomic resources and materials, to provide access to state-ofthe- art post-genomic instrumentation, and to provide expert assistance in performing post-genomic experiments, and bioinformatics, resulting in enhanced research opportunities for investigators at reduced costs. The GP-Core accomplishes this goal by producing whole genome mouse and pathogen DMA arrays and other molecular detection tools and platforms, by providing and maintaining post-genomic instrumentation in a centralized facility adjacent to the BL-3 laboratories, and by performing experimentation for investigators who would otherwise not be able to perform experiments because of a lack of manpower or expertise, and providing access to bioinformatics resources, staff, and support. The GP-Core also develops technology and custom platforms for investigators for focused or more advanced post-genomic studies. Accordingly, the GP-Core (1) produces and develops post-genomic resources for investigators, (2) provides access to post-genomic equipment (3) provides genomics, proteomics, and bioinformatics assistance and technical expertise, and (4) provides bioinformatics and Computer-Aided Drug Design (CADD) services to advance diagnostic and therapeutic drug discovery, design, and development for RMRCE investigators. Together, the activities of the GP-Core support research objectives on infectious diseases important to public health by providing resources and equipment that are required for post-genomic studies, technical assistance for experimental design, data analysis and other bioinformatics-related analyses, and postgenomic services on a fee-for-services basis. Core E will support all three of the RMRCE Integrated Research Foci on Immunomodulation, Adjuvants and Vaccines (IRF 1), Bacterial Therapeutics (IRF 2), and Viral Therapeutics (IRF 3). Its resources will be utilized by RPs 1.4, 1.6, 1.7, 2.1, 2.2, 2.3, 2.4, 2.5, 2.7 and 3.4

View original record on NIH RePORTER →